Moderna Inc (MRNA)
38.26
+1.32
(+3.57%)
USD |
NASDAQ |
Nov 21, 16:00
38.21
-0.05
(-0.13%)
After-Hours: 20:00
Moderna Shareholders Equity (Quarterly): 11.93B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 11.93B |
June 30, 2024 | 11.71B |
March 31, 2024 | 12.82B |
December 31, 2023 | 13.85B |
September 30, 2023 | 13.46B |
June 30, 2023 | 16.95B |
March 31, 2023 | 18.86B |
December 31, 2022 | 19.12B |
September 30, 2022 | 17.99B |
June 30, 2022 | 17.98B |
March 31, 2022 | 17.08B |
December 31, 2021 | 14.14B |
September 30, 2021 | 10.12B |
Date | Value |
---|---|
June 30, 2021 | 6.704B |
March 31, 2021 | 3.838B |
December 31, 2020 | 2.561B |
September 30, 2020 | 2.760B |
June 30, 2020 | 2.947B |
March 31, 2020 | 1.641B |
December 31, 2019 | 1.175B |
September 30, 2019 | 1.252B |
June 30, 2019 | 1.339B |
March 31, 2019 | 1.446B |
December 31, 2018 | 1.530B |
September 30, 2018 | 1.076B |
December 31, 2017 | 625.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.175B
Minimum
Dec 2019
19.12B
Maximum
Dec 2022
10.88B
Average
12.37B
Median
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 14.24B |
Merck & Co Inc | 44.50B |
Pfizer Inc | 92.29B |
Novavax Inc | -526.44M |
Vertex Pharmaceuticals Inc | 15.63B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 15.80B |
Total Liabilities (Quarterly) | 3.876B |
Current Ratio | 4.392 |